Inventor · disambiguated record
Colin Hislop
Also filed as: HISLOP COLIN · HISLOP COLIN MICHAEL
1 granted patent·12 pending applications·2 citations·filing 2007–2023
21Inventor score
Top patents by PatentIndex Score
13 records- 0166US8048880B2Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A2 (SPLA2) inhibitors and SPLA2 inhibitor combination therapiesANTHERA PHARMACEUTICALS INC·Filed 2008·Granted Nov 1, 2011·2 cites·30 claims
- 0261US2024207243A1Method of treating laminopathiesEIGER BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0355US2023201308A1Treatment of coronavirus infection with interferon lambdaEIGER BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0454US2021121454A1Method of treating laminopathiesEIGER BIOPHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0552US2021267961A1Method of treating laminopathiesEIGER BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0648US2023285510A1Treatment of coronavirus infection with interferon lambdaEIGER BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0739US2010160361A1Treatment of major adverse cardiac events and acute coronary syndrome using secretory phospholipase a2 (spla2) inhibitor or spla2 inhibitor combination therapiesHISLOP COLIN·Filed 2009·Application pending·0 cites
- 0835US2009062369A1Use of secretory phospholipase a2 (spla2) inhibitors to decrease spla2 levelsTRIAS JOAQUIM·Filed 2007·Application pending·0 cites
- 0931US2011269786A1Treatment of major adverse cardiac events and acute coronary syndrome in diabetic patients using secretory phospholipase a2 (spla2) inhibitor or spla2 inhibitor combination therapiesHISLOP COLIN·Filed 2011·Application pending·0 cites
- 1030US2011301202A1Spla2 inhibitor conjugate compounds and methods of useHISLOP COLIN·Filed 2011·Application pending·0 cites
- 1129US2011207710A1Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase a2 (spla2) inhibitors and spla2 inhibitor combination therapiesTRIAS JOAQUIM·Filed 2011·Application pending·0 cites
- 1226US2017369551A1METHODS OF TREATING IgA NEPHROPATHY AND HENOCH-SCHONLEIN PURPURA NEPHRITIS USING A B-CELL ACTIVATING FACTOR (BAFF) INHIBITORANTHERA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1319US2010204249A1Secretory phospholipase a2 (spla2) inhibitor and niacin drug compositions and methods for treating cardiovascular disease and dyslipidemiaHISLOP COLIN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Colin Hislop files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →